Septerna (SEPN) Earnings Date & Reports

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

SEPN is expected to report earnings to rise 28.57% to -62 cents per share on September 03

Q2'25

Est.

$-0.63

Q1'25

Beat

by $0.05

The last earnings report on May 15 showed earnings per share of -49 cents, beating the estimate of -54 cents. With 299.66K shares outstanding, the current market capitalization sits at 453.16M.

View a ticker or compare two or three

Compare

SEPN